Effects of the Notch Signaling Pathway on Secondary Brain Changes Caused by Spinal Cord Injury in Mice

Chengcai Li1, Shaoxin Huang2, Wu Zhou1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China.

Neurochemical Research
|February 25, 2022
PubMed

Insights

Spinal cord injury causes brain hypomyelination, linked to neuropathic pain. Inhibiting the Notch signaling pathway with DAPT may treat this pain by improving myelination in the dorsolateral prefrontal cortex.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Spinal cord injury (SCI) can induce secondary brain alterations, specifically hypomyelination in the dorsolateral prefrontal cortex (dlPFC).
  • The Notch signaling pathway plays a crucial role in regulating oligodendrocyte development and myelination processes.
  • Neuropathic pain is a common and debilitating consequence of SCI.

Purpose of the Study:

  • To investigate if inhibiting the Notch signaling pathway can mitigate SCI-induced hypomyelination in the dlPFC.
  • To explore the association between dlPFC myelination changes and the development of neuropathic pain post-SCI.

Main Methods:

  • Establishment of a mouse model of spinal cord injury.
  • Assessment of mechanical and thermal hyperalgesia to evaluate neuropathic pain.
  • Analysis of myelination changes in the dlPFC using Western blotting and immunofluorescence.

Main Results:

  • Activation of the Notch signaling pathway was observed following SCI, correlating with dlPFC hypomyelination.
  • Hypomyelination in the dlPFC was found to be associated with reduced thresholds for mechanical and thermal hyperalgesia.
  • Treatment with DAPT, a Notch inhibitor, improved hyperalgesia thresholds, suggesting a reversal of myelination deficits.

Conclusions:

  • The Notch signaling pathway is activated after SCI, contributing to hypomyelination in the dlPFC.
  • DAPT effectively inhibits the Notch pathway, ameliorating neuropathic pain symptoms by improving myelination.
  • Targeting the Notch signaling pathway presents a potential therapeutic strategy for managing SCI-related neuropathic pain.